Clinical Trials List
Protocol NumberLUKCT-01-01
Active
2017-12-01 - 2019-12-01
Phase I/II
Terminated1
ICD-10C14.0
Malignant neoplasm of pharynx, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9149.0
Malignant neoplasm of pharynx, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
15 participants
